Guidelines for the Management of Sexually Transmitted Infections. February 2004
(2004; 88 pages)
Table of Contents
View the documentPREFACE
Open this folder and view contents1. INTRODUCTION
Open this folder and view contents2. TREATMENT OF STI-ASSOCIATED SYNDROMES
Close this folder3. TREATMENT OF SPECIFIC INFECTIONS
Open this folder and view contents3.1. Gonococcal infections
Open this folder and view contents3.2. Chlamydia trachomatis infections (other than lymphogranuloma venereum)
View the document3.3. Lymphogranuloma venereum
Open this folder and view contents3.4. Syphilis
View the document3.5. Chancroid
View the document3.6. Granuloma inguinale (Donovanosis)
Close this folder3.7. Genital herpes infections
View the documentFirst clinical episode
View the documentRecurrent infections
View the documentSuppressive therapy
View the documentHerpes in pregnancy
View the documentHerpes and HIV co-infection
Open this folder and view contents3.8. Venereal warts
View the document3.9. Trichomonas vaginalis infections
Open this folder and view contents3.10. Bacterial vaginosis
Open this folder and view contents3.11. Candidiasis
View the document3.12. Scabies
View the document3.13. Phthiriasis (pediculosis pubis)
Open this folder and view contents4. KEY CONSIDERATIONS UNDERLYING TREATMENTS
Open this folder and view contents5. PRACTICAL CONSIDERATIONS IN STI CASE MANAGEMENT
Open this folder and view contents6. CHILDREN6, ADOLESCENTS AND SEXUALLY TRANSMITTED INFECTIONS
View the documentANNEX. LIST OF PARTICIPANTS
 

Recurrent infections

Most patients with a first-episode of genital herpes infection will have recurrent episodes of genital lesions. Episodic or suppressive antiviral therapy will shorten the duration of genital lesions. Because many patients benefit from antiviral therapy, options for treatment should be discussed with all patients.

When treatment is started during the prodrome or within 1 day after onset of lesions, many patients who have recurrent disease benefit from episodic therapy. If episodic treatment of recurrences is chosen, the patient should be provided with antiviral therapy, or a prescription for the medication, so that treatment can be initiated at first sign of prodrome or genital lesions.

Recommended regimen

• acyclovir, 200mg orally, 5 times daily for 5 days

OR

• acyclovir 400mg 3 times daily for 5 days

OR

• acyclovir 800mg orally twice daily for 5 days

OR

• famciclovir 125mg orally twice daily for 5 days

OR

• valaciclovir 500mg orally twice daily for 5 days

OR

• valaciclovir 1 000mg orally once daily for 5 days

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019